Initial Diagnosis and Treatment of Low-Risk Gestational Trophoblastic Neoplasia

被引：0
|
作者：
Alimena, Stephanie [1 ,2 ,3 ]
Elias, Kevin M. [1 ,2 ,3 ]
Horowitz, Neil S. [1 ,2 ,3 ]
Berkowitz, Ross S. [1 ,2 ,3 ]
机构：
[1] Brigham & Womens Hosp, Dept Obstet & Gynecol, Div Gynecol Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2024年 / 38卷 / 06期
关键词：
Gestational trophoblastic neoplasia; Low risk; Chemotherapy; Methotrexate; Dactinomycin; Immunotherapy; Hysterectomy; Second dilation and curettage; ACTINOMYCIN-D; FOLINIC ACID; METHOTREXATE INFUSION; PULSE DACTINOMYCIN; PRIMARY THERAPY; DISEASE; CHEMOTHERAPY; MANAGEMENT; EXPERIENCE; RESISTANCE;
D O I：
10.1016/j.hoc.2024.07.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Though low-risk GTN is a highly curable disease, due to strong productive research, we can continue to advance understanding of how to minimize relapses, lessen toxicity of treatment, and help women to maintain their quality of life and fertility after treatment for GTN.
引用
收藏
页码：1233 / 1244
页数：12
相关论文
共 50 条
  • [21] Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
    Seresht, Leila Mousavi
    Farazestanian, Marjaneh
    Yousefi, Zohreh
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 108 - 111
  • [22] OUTCOME OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN) TREATED WITH METHOTREXATE
    Alobaid, A.
    Ahmeed, S.
    Saleh, R.
    Mattar, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [23] First-line chemotherapy in low-risk gestational trophoblastic neoplasia
    Alazzam, Mo'iad
    Tidy, John
    Hancock, Barry W.
    Osborne, Raymond
    Lawrie, Theresa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (07):
  • [24] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [25] Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia
    Yarandi, Fariba
    Eftekhar, Zahra
    Shojaei, Hadi
    Kanani, Soheyla
    Sharifi, Ali
    Hanjani, Parviz
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (01) : 33 - 37
  • [26] SINGLE-DOSE METHOTREXATE IN THE TREATMENT OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA - AN UPDATED RESULTS
    Ngu, S. F.
    Tse, K. Y.
    Chu, M. Y. M.
    Sheung, P. N. H.
    Chan, K. L. K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A140 - A140
  • [27] Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia
    Mahajan, Niraj N.
    Soni, Rajani N.
    Mahajan, Kshitija N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (03) : 325 - 325
  • [28] 5-Fluorouracil as first-line treatment for low-risk gestational trophoblastic neoplasia
    Chen, Dan
    Yang, Yanfeng
    Li, Yitong
    Zhao, Yining
    Zhang, Xin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (12) : 2677 - 2684
  • [29] Efficacy of Combination Therapy with Actinomycin D and Methotrexate in the Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Kang, Hai-Li
    Zhao, Qun
    Yang, Shu-Li
    Duan, Wei
    CHEMOTHERAPY, 2019, 64 (01) : 42 - 47
  • [30] The diagnostics and treatment of low-risk gestational trophoblastic neoplasia (GTN): 42-year experience
    Fulop, Vilmos
    Szigetvari, Ivan
    Szepesi, Janos
    Lahm, Erika
    Vegh, Gyorgy
    Demeter, Janos
    Papai, Zsuzsanna
    Berkowitz, Ross S.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (06) : 1159 - 1165
12345